The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 11, 2015

Filed:

Mar. 14, 2013
Applicant:

The Administrators of the Tulane Educational Fund, New Orleans, LA (US);

Inventors:

Robert Francis Garry, New Orleans, LA (US);

Luis Manuel Branco, Germantown, MD (US);

Bruce Alan Bunnell, Mandeville, LA (US);

Russell B. Wilson, Mandeville, LA (US);

Samuel E. Hopkins, Raleigh, NC (US);

Assignees:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A01N 63/00 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61K 39/42 (2006.01); C12N 5/00 (2006.01); C12N 5/07 (2010.01); A61K 35/28 (2015.01);
U.S. Cl.
CPC ...
A61K 35/28 (2013.01);
Abstract

Immunoprotective primary mesenchymal stems cells (IP-MSC) which episomally express multiple immunoreactive polypeptides that specifically target a pathogen (e.g., an infectious species of virus, bacterium, or parasite) or toxin are described herein. The IP-MSC express two or more (e.g., 2 to about 100) immunoreactive polypeptides (e.g., full antibodies, single-chain antibodies (ScFV), Fab or F(ab)antibody fragments, diabodies, tribodies, and the like), and optionally one or more other immunomodulating polypeptides, e.g., a cytokine such as an interleukin (e.g., IL-2, IL-4, IL-6, IL-7, IL-9, and IL-12), an interferon (e.g., IFNα, IFNβ, or IFNω), and the like, which can enhance the effectiveness of the immunoreactive polypeptides.


Find Patent Forward Citations

Loading…